Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test

Theoretical Biology and Medical Modelling

Volumn 7, Issue 1, 2010, Pages

  Panunzi, Simona ^a   De Gaetano, Andrea ^a   Mingrone, Geltrude ^b  

^a CNR   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE;

GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MODELS, BIOLOGICAL;

EID: 77951438555     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-7-9     Document Type: Article

References (34)

1. Insulin resistance: the fundamental trigger of type 2 diabetes. LC Groop, Diabetes Obes Metab 1999 1 1 S7 10.1046/j.1463-1326.1999.0010s1001.x 11220283
2. Clinical review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment. R Mahler M Adler, J Clin Endocrinol Metab 1999 84 1165 1171 10.1210/jc.84.4.1165 10199747 (Pubitemid 30644370)
3. Insulin and cardiovascular disease: Paris prospective study. A Fontbonne E Eschwege, Diabetes Care 1991 14 461 469 10.2337/diacare.14.6.461 1864219
4. Insulin resistance in essential hypertension. E Ferrannini G Buzzigoli R Bonadonna M Giorico M Oleggini L Graziadei, et al. N Engl J Med 1987 317 350 357 3299096 (Pubitemid 17118813)
5. Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease. J Després B Lamarche P Mauriège B Cantin G Dagenais S Moorjani, et al. N Engl J Med 1996 334 952 958 10.1056/NEJM199604113341504 8596596 (Pubitemid 26314456)
6. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'. P Kincaid-Smith, J Hypertens 2004 22 1051 1055 10.1097/00004872-200406000-00001 15167435 (Pubitemid 38720992)
7. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. G Farrell C Larter, Hepatology 2006 43 99 S112 10.1002/hep.20973 16447287 (Pubitemid 43303974)
8. Epidemiology of the insulin resistance syndrome. G Meigs, Curr Diab Rep 2003 3 73 79 10.1007/s11892-003-0057-2 12643149
9. Insulin resistance - the new goal! P Peter S Nuttall M Kendall, J Clin Pharm Ther 2003 28 167 174 10.1046/j.1365-2710.2003.00482.x 12795774 (Pubitemid 36783092)
10. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). E Ferrannini A Natali P Bell P Cavallo Perin N Lalic G Mingrone, J Clin Invest 1997 100 1166 1173 10.1172/JCI119628 9303923
11. Quantitative estimation of insulin sensitivity. RN Bergman YZ Ider CR Bowden C Cobelli, Am J Physiol 1979 236 667 E677 443421 (Pubitemid 9220487)
12. Reassessment of glucose effectiveness and insulin sensitivity from minimal model analysis: a theoretical evaluation of the single-compartment glucose distribution assumption. TC Ni M Ader EN Bergman, Diabetes 1997 46 1813 1821 10.2337/diabetes.46.11.1813 9356031 (Pubitemid 27456416)
13. A discrete Single Delay Model for the Intra-Venous Glucose Tolerance Test. S Panunzi P Palumbo A De Gaetano, Theoretical Biology and Medical Modelling 2007 4 10.1186/1742-4682-4-35 17850652 (Pubitemid 350103414)
14. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. G Pacini RN Bergman, Comput Methods Programs Biomed 1986 23 113 122 10.1016/0169-2607(86)90106-9 3640682 (Pubitemid 16027716)
15. Qualitative behavior of a family of delay-differential models of the glucose-insulin system. P Palumbo S Panunzi A De Gaetano, Discrete and Continuous Dynamical Systems - Series B 2007 7 399 424
16. Glucose clamp technique: a method for quantifying insulin secretion and resistance. RA Defronzo JD Tobin R Andres, Am J Physiol 1979 237 214 E223 382871
17. M Davidian DM Giltinan, Nonlinear Models for Repeated Measurement Data 1995
18. Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. G Toffolo RN Bergman DT Finegood CR Bowden C Cobelli, Diabetes 1980 29 979 990 10.2337/diabetes.29. 12.979 7002673 (Pubitemid 11017924)
19. WH Press BP Flannery SA Teukolsky WT Vetterling, Numerical recipes in C. The art of scientific computing Cambridge: Cambridge University Press 2 1994
20. Surrogate indexes vs. euglycaemic-hyperinsulinemic clamp as an indicator of insulin resistance and cardiovascular risk factors in overweight and obese postmenopausal women. F Malita A Karelis D St-Pierre D Garrel J Bastard A Tardif, et al. Diabetes & Metabolism 2006 32 251 255 (Pubitemid 43966749)
21. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. M Ciampelli F Leoni F Cucinelli S Mancuso S Panunzi A De Gaetano, et al. J Clin Endocrinol Metab 2005 90 1398 1406 10.1210/jc.2004-0410 15598698 (Pubitemid 40463995)
22. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
23. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. M Emoto Y Nishizawa K Maekawa Y Hiura H Kanda T Kawagishi, et al. Diabetes Care 1999 22 818 822 10.2337/diacare.22.5.818 10332688 (Pubitemid 29220786)
24. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. E Bonora G Targher M Alberiche R Bonadonna F Saggiani MB Zenere, et al. Diabetes Care 2000 23 57 63 10.2337/diacare.23.1.57 10857969 (Pubitemid 30022895)
25. Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment in Normal Range Weight and Moderately Obese Type 2 Diabetic Patients. H Yokoyama M Emoto S Fujiwara K Motoyama T Morioka M Komatsu, et al. Diabetes Care 2003 26 2426 2432 10.2337/diacare.26.8.2426 12882874 (Pubitemid 36993338)
26. HOMA Calculator. The Oxford Centre for Diabetes Endocrinology & Metabolism Diabetes Trial Unit 2009
27. Quantification of the relationship between insulin sensitivity and b-cell function in human subjects. SE Kahn RL Prigeon DK McCulloch EJ Boyco RN Bergman MW Schwartz, et al. Diabetes 1993 42 1663 1672 10.2337/diabetes.42.11.1663 8405710
28. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. RN Bergman, Diabetes 1989 38 1512 1527 10.2337/diabetes.38.12.1512 2684710
29. Mathematical modelling of the intravenous glucose tolerance test. A De Gaetano O Arino, J Math Biol 2000 40 136 168 10.1007/s002850050007 10743599
30. Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. E Van Cauter, American Journal of Physiology-Endocrinology and Metabolism 1988 254 786 E794
31. Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. C Cobelli A Caumo M Omenetto, Am J Physiol Endocrinol Metab 1999 277 481 488 (Pubitemid 29458208)
32. A new dynamic index of insulin sensitivity. G Pillonetto A Caumo G Sparacino C Cobelli, Ieee Transactions on Biomedical Engineering 2006 53 369 379 10.1109/TBME.2005.869654 16532763 (Pubitemid 43288814)
33. Numerical non-identifiability regions of the minimal model of glucose kinetics: superiority of Bayesian estimation. G Pillonetto G Sparacino C Cobelli, Math Biosci 2003 184 53 67 10.1016/S0025-5564(03)00044-0 12788233 (Pubitemid 36736883)
34. Beta-Cell Function in Obesity. Effects of Weight Loss. E Ferrannini S Camastra A Gastaldelli A Sironi A Natali E Muscelli, et al. Diabetes 2004 53 26 S33 10.2337/diabetes.53.suppl-3.S26 15561918 (Pubitemid 39564519)